Zogenix Files for IPO

Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol ZGNX, with Banc of America Securities serving as lead underwriter.

 

The company has raised $78 million in VC funding from Domain Associates (23.2% pre-IPO stake), Clarus Ventures (23.1%), Scale Venture Partners (15.4%), Thomas McNerney & Partners (13.2%) and Abingworth Ventures (10%). www.zogenix.com